Hybrid Molecules with Potential Activity against Drug-resistant Cancer (Part II)
Curr Top Med Chem
.
2022;22(17):1392.
doi: 10.2174/156802662217220720144604.
Author
Lian-Shun Feng
1
Affiliation
1
Peking University Beijing, P.R. China.
PMID:
36028932
DOI:
10.2174/156802662217220720144604
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Agents*
Humans
Neoplasms*
Substances
Antineoplastic Agents